InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Fox Christine Ann. Director active across 1 company, notably Mereo BioPharma Group plc. Cumulatively, 4 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €82k. Activity tracked since 21 June 2024. The latest transaction was disclosed on 12 September 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Fox Christine Ann is a declarant linked to Mereo BioPharma Group plc, where she serves as Chief Financial Officer. She has 4 filings in total, and within the sampled recent filings from 2024-06-25 to 2024-09-16, sales total EUR 81659 and the modal transaction nature is Sale.